language-icon Old Web
English
Sign In

Dalantercept

ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. About 4-7% of non-small cell lung carcinomas (NSCLC) have EML4-ALK translocations.

[ "Phases of clinical research", "SUPERFAMILY", "Fusion protein", "Vascular endothelial growth factor", "Renal cell carcinoma" ]
Parent Topic
Child Topic
    No Parent Topic